Juvenile Idiopathic Arthritis Associated Uveitis
Related Experiment Video
Updated: Oct 22, 2025

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Emil Carlsson1, Michael W Beresford1,2,3, Athimalaipet V Ramanan4
1Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool L14 5AB, UK.
Insights
Juvenile idiopathic arthritis (JIA) can lead to vision loss through associated uveitis. This review explores genetic and molecular factors to identify at-risk children and improve JIA-uveitis treatment strategies.
Area of Science:
- Rheumatology
- Ophthalmology
- Genetics
Background:
- Juvenile idiopathic arthritis (JIA) is a common childhood rheumatic condition.
- JIA-associated uveitis poses a significant risk of vision loss.
- Early detection and treatment are crucial but challenging due to asymptomatic onset.
Purpose of the Study:
- To review genomic, transcriptomic, and proteomic factors associated with JIA-uveitis risk.
- To discuss current therapeutic strategies for JIA-uveitis.
Main Methods:
- Literature review of genomic, transcriptomic, and proteomic studies.
- Analysis of identified risk factors in JIA patients.
Main Results:
- Several genomic, transcriptomic, and proteomic factors have been identified as potential risk indicators for JIA-uveitis.
- Understanding these factors can aid in risk stratification.
Conclusions:
- Identifying specific risk factors is key to proactive management of JIA-uveitis.
- Further research into pathogenic drivers will refine therapeutic approaches and improve visual outcomes for children with JIA.
Abstract:
Juvenile idiopathic arthritis (JIA) is the most common childhood rheumatic disease. The development of associated uveitis represents a significant risk for serious complications, including permanent loss of vision. Initiation of early treatment is important for controlling JIA-uveitis, but the disease can appear asymptomatically, making frequent screening procedures necessary for patients at risk. As our understanding of pathogenic drivers is currently incomplete, it is difficult to assess which JIA patients are at risk of developing uveitis. Identification of specific risk factors for JIA-associated uveitis is an important field of research, and in this review, we highlight the genomic, transcriptomic, and proteomic factors identified as potential uveitis risk factors in JIA, and discuss therapeutic strategies.
More Related Videos
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Nephrotic Syndrome I : Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Pericarditis I: Introduction
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

